Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Backlog Grows by 18.9% Year-Over-Year with TTM Book-to-Bill Ratio of 1.3x Repurchased $202 Million of our Shares During Q1 Board Authorizes $1.5 Billion for Company's ...

Hubbell Incorporated (NYSE: HUBB) today reported operating results for the fourth quarter and full year ended December 31, 2024. "Hubbell delivered double-digit growth in operating profit, earnings ...